nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—Ursodeoxycholic acid—SLC10A2—esophageal cancer	0.0218	0.708	CrCbGaD
Chenodeoxycholic acid—Ursodeoxycholic acid—ABCC2—esophageal cancer	0.00488	0.159	CrCbGaD
Chenodeoxycholic acid—Drostanolone—CYP19A1—esophageal cancer	0.0041	0.133	CrCbGaD
Chenodeoxycholic acid—NR1H4—digestive system—esophageal cancer	0.00275	0.169	CbGeAlD
Chenodeoxycholic acid—CYP27A1—bronchus—esophageal cancer	0.00259	0.159	CbGeAlD
Chenodeoxycholic acid—CYP27A1—trachea—esophageal cancer	0.00233	0.143	CbGeAlD
Chenodeoxycholic acid—CYP27A1—digestive system—esophageal cancer	0.002	0.123	CbGeAlD
Chenodeoxycholic acid—UGT2B7—digestive system—esophageal cancer	0.00177	0.109	CbGeAlD
Chenodeoxycholic acid—CYP27A1—lung—esophageal cancer	0.00167	0.102	CbGeAlD
Chenodeoxycholic acid—NR1H4—lymph node—esophageal cancer	0.00157	0.0963	CbGeAlD
Chenodeoxycholic acid—Cardiac failure—Capecitabine—esophageal cancer	0.00155	0.0038	CcSEcCtD
Chenodeoxycholic acid—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00155	0.00379	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Cisplatin—esophageal cancer	0.00154	0.00377	CcSEcCtD
Chenodeoxycholic acid—Melaena—Methotrexate—esophageal cancer	0.00152	0.00372	CcSEcCtD
Chenodeoxycholic acid—Cystitis noninfective—Methotrexate—esophageal cancer	0.00152	0.00372	CcSEcCtD
Chenodeoxycholic acid—Diplopia—Capecitabine—esophageal cancer	0.00152	0.00371	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00152	0.00371	CcSEcCtD
Chenodeoxycholic acid—Cystitis—Methotrexate—esophageal cancer	0.0015	0.00367	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Cisplatin—esophageal cancer	0.0015	0.00367	CcSEcCtD
Chenodeoxycholic acid—Migraine—Capecitabine—esophageal cancer	0.00149	0.00365	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP26A1—esophageal cancer	0.00147	0.0027	CbGpPWpGaD
Chenodeoxycholic acid—Vaginal infection—Methotrexate—esophageal cancer	0.00147	0.00359	CcSEcCtD
Chenodeoxycholic acid—Face oedema—Capecitabine—esophageal cancer	0.00146	0.00358	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00145	0.00266	CbGpPWpGaD
Chenodeoxycholic acid—Blood creatinine increased—Capecitabine—esophageal cancer	0.00142	0.00347	CcSEcCtD
Chenodeoxycholic acid—Dehydration—Capecitabine—esophageal cancer	0.00141	0.00345	CcSEcCtD
Chenodeoxycholic acid—Ecchymosis—Methotrexate—esophageal cancer	0.00141	0.00344	CcSEcCtD
Chenodeoxycholic acid—Bladder pain—Methotrexate—esophageal cancer	0.00141	0.00344	CcSEcCtD
Chenodeoxycholic acid—Neoplasm—Methotrexate—esophageal cancer	0.00141	0.00344	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Cisplatin—esophageal cancer	0.0014	0.00344	CcSEcCtD
Chenodeoxycholic acid—Liver function test abnormal—Capecitabine—esophageal cancer	0.0014	0.00342	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Cisplatin—esophageal cancer	0.0014	0.00342	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Cisplatin—esophageal cancer	0.00139	0.00341	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—NFE2L2—esophageal cancer	0.00139	0.00255	CbGpPWpGaD
Chenodeoxycholic acid—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00138	0.00339	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain upper—Capecitabine—esophageal cancer	0.00138	0.00339	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Cisplatin—esophageal cancer	0.00137	0.00335	CcSEcCtD
Chenodeoxycholic acid—Breast disorder—Capecitabine—esophageal cancer	0.00137	0.00335	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTO1—esophageal cancer	0.00137	0.00251	CbGpPWpGaD
Chenodeoxycholic acid—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00136	0.00334	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP1B1—esophageal cancer	0.00135	0.00249	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—GSTO1—esophageal cancer	0.00135	0.00248	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.00135	0.00247	CbGpPWpGaD
Chenodeoxycholic acid—Gastritis—Capecitabine—esophageal cancer	0.00134	0.00328	CcSEcCtD
Chenodeoxycholic acid—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00134	0.00327	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Cisplatin—esophageal cancer	0.00133	0.00325	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Cisplatin—esophageal cancer	0.00133	0.00325	CcSEcCtD
Chenodeoxycholic acid—Lymphadenopathy—Methotrexate—esophageal cancer	0.00132	0.00324	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Cisplatin—esophageal cancer	0.00132	0.00323	CcSEcCtD
Chenodeoxycholic acid—Influenza—Capecitabine—esophageal cancer	0.00131	0.00321	CcSEcCtD
Chenodeoxycholic acid—Asthma—Capecitabine—esophageal cancer	0.00131	0.00321	CcSEcCtD
Chenodeoxycholic acid—Dysphagia—Capecitabine—esophageal cancer	0.00131	0.00321	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00131	0.0024	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00129	0.00238	CbGpPWpGaD
Chenodeoxycholic acid—Photosensitivity—Methotrexate—esophageal cancer	0.00128	0.00314	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Cisplatin—esophageal cancer	0.00128	0.00314	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Cisplatin—esophageal cancer	0.00128	0.00314	CcSEcCtD
Chenodeoxycholic acid—Angina pectoris—Capecitabine—esophageal cancer	0.00128	0.00312	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP19A1—esophageal cancer	0.00127	0.00234	CbGpPWpGaD
Chenodeoxycholic acid—Arrhythmia—Cisplatin—esophageal cancer	0.00127	0.00311	CcSEcCtD
Chenodeoxycholic acid—Bronchitis—Capecitabine—esophageal cancer	0.00126	0.00308	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Cisplatin—esophageal cancer	0.00126	0.00308	CcSEcCtD
Chenodeoxycholic acid—Abdominal discomfort—Capecitabine—esophageal cancer	0.00126	0.00307	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00124	0.00228	CbGpPWpGaD
Chenodeoxycholic acid—Malnutrition—Cisplatin—esophageal cancer	0.00124	0.00303	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00124	0.00227	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00124	0.00227	CbGpPWpGaD
Chenodeoxycholic acid—Dysuria—Capecitabine—esophageal cancer	0.00122	0.003	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Cisplatin—esophageal cancer	0.00122	0.00299	CcSEcCtD
Chenodeoxycholic acid—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00122	0.00298	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00121	0.00222	CbGpPWpGaD
Chenodeoxycholic acid—Photosensitivity reaction—Capecitabine—esophageal cancer	0.0012	0.00293	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—CYP2A6—esophageal cancer	0.00119	0.00219	CbGpPWpGaD
Chenodeoxycholic acid—Weight increased—Capecitabine—esophageal cancer	0.00119	0.00292	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Cisplatin—esophageal cancer	0.00119	0.00291	CcSEcCtD
Chenodeoxycholic acid—Weight decreased—Capecitabine—esophageal cancer	0.00119	0.0029	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.00118	0.00217	CbGpPWpGaD
Chenodeoxycholic acid—Pneumonia—Capecitabine—esophageal cancer	0.00117	0.00288	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00117	0.00215	CbGpPWpGaD
Chenodeoxycholic acid—Infestation—Capecitabine—esophageal cancer	0.00117	0.00286	CcSEcCtD
Chenodeoxycholic acid—Infestation NOS—Capecitabine—esophageal cancer	0.00117	0.00286	CcSEcCtD
Chenodeoxycholic acid—Depression—Capecitabine—esophageal cancer	0.00116	0.00285	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.00116	0.00212	CbGpPWpGaD
Chenodeoxycholic acid—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00115	0.00282	CcSEcCtD
Chenodeoxycholic acid—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00115	0.00282	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Cisplatin—esophageal cancer	0.00115	0.00281	CcSEcCtD
Chenodeoxycholic acid—Renal failure—Capecitabine—esophageal cancer	0.00115	0.00281	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—lymph node—esophageal cancer	0.00114	0.0701	CbGeAlD
Chenodeoxycholic acid—Myocardial infarction—Capecitabine—esophageal cancer	0.00114	0.0028	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Cisplatin—esophageal cancer	0.00114	0.0028	CcSEcCtD
Chenodeoxycholic acid—Jaundice—Capecitabine—esophageal cancer	0.00114	0.00279	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Capecitabine—esophageal cancer	0.00114	0.00278	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Capecitabine—esophageal cancer	0.00114	0.00278	CcSEcCtD
Chenodeoxycholic acid—Malaise—Cisplatin—esophageal cancer	0.00112	0.00273	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Orphan transporters—CREBBP—esophageal cancer	0.00112	0.00205	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—ALDH2—esophageal cancer	0.00111	0.00205	CbGpPWpGaD
Chenodeoxycholic acid—Haematuria—Capecitabine—esophageal cancer	0.00111	0.00273	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Cisplatin—esophageal cancer	0.00111	0.00271	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00111	0.00203	CbGpPWpGaD
Chenodeoxycholic acid—Hepatobiliary disease—Capecitabine—esophageal cancer	0.0011	0.0027	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Capecitabine—esophageal cancer	0.0011	0.0027	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.0011	0.00202	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—NR1I2—esophageal cancer	0.00108	0.00198	CbGpPWpGaD
Chenodeoxycholic acid—Convulsion—Cisplatin—esophageal cancer	0.00107	0.00263	CcSEcCtD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—CREBBP—esophageal cancer	0.00107	0.00196	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTT1—esophageal cancer	0.00106	0.00195	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00106	0.00194	CbGpPWpGaD
Chenodeoxycholic acid—Myalgia—Cisplatin—esophageal cancer	0.00105	0.00258	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00105	0.00194	CbGpPWpGaD
Chenodeoxycholic acid—Haemoglobin—Capecitabine—esophageal cancer	0.00105	0.00258	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Capecitabine—esophageal cancer	0.00105	0.00257	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Capecitabine—esophageal cancer	0.00105	0.00257	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP2A6—esophageal cancer	0.00105	0.00192	CbGpPWpGaD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00105	0.00256	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—esophageal cancer	0.00104	0.00192	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00104	0.00192	CbGpPWpGaD
Chenodeoxycholic acid—Liver function test abnormal—Methotrexate—esophageal cancer	0.00104	0.00255	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Cisplatin—esophageal cancer	0.00104	0.00255	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Capecitabine—esophageal cancer	0.00104	0.00255	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Capecitabine—esophageal cancer	0.00104	0.00253	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Capecitabine—esophageal cancer	0.00103	0.00253	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Capecitabine—esophageal cancer	0.00103	0.00252	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Capecitabine—esophageal cancer	0.00103	0.00252	CcSEcCtD
Chenodeoxycholic acid—Breast disorder—Methotrexate—esophageal cancer	0.00102	0.0025	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.00102	0.00187	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00101	0.00186	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00101	0.00186	CbGpPWpGaD
Chenodeoxycholic acid—Oedema—Cisplatin—esophageal cancer	0.00101	0.00247	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Capecitabine—esophageal cancer	0.00101	0.00247	CcSEcCtD
Chenodeoxycholic acid—Infection—Cisplatin—esophageal cancer	0.001	0.00246	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—PTGS1—esophageal cancer	0.000993	0.00182	CbGpPWpGaD
Chenodeoxycholic acid—Nervous system disorder—Cisplatin—esophageal cancer	0.000991	0.00243	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Cisplatin—esophageal cancer	0.000989	0.00242	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Cisplatin—esophageal cancer	0.000986	0.00241	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Cisplatin—esophageal cancer	0.000982	0.0024	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Capecitabine—esophageal cancer	0.00098	0.0024	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Capecitabine—esophageal cancer	0.000978	0.00239	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Cisplatin—esophageal cancer	0.000977	0.00239	CcSEcCtD
Chenodeoxycholic acid—Asthma—Methotrexate—esophageal cancer	0.000975	0.00239	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Capecitabine—esophageal cancer	0.000973	0.00238	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Cisplatin—esophageal cancer	0.000963	0.00236	CcSEcCtD
Chenodeoxycholic acid—Pancreatitis—Methotrexate—esophageal cancer	0.000956	0.00234	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Capecitabine—esophageal cancer	0.000951	0.00233	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Capecitabine—esophageal cancer	0.000947	0.00232	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Capecitabine—esophageal cancer	0.000945	0.00231	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Cisplatin—esophageal cancer	0.000944	0.00231	CcSEcCtD
Chenodeoxycholic acid—Chills—Capecitabine—esophageal cancer	0.000941	0.0023	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—BLVRB—esophageal cancer	0.000937	0.00172	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—SLC52A3—esophageal cancer	0.000937	0.00172	CbGpPWpGaD
Chenodeoxycholic acid—Arrhythmia—Capecitabine—esophageal cancer	0.000937	0.00229	CcSEcCtD
Chenodeoxycholic acid—Abdominal discomfort—Methotrexate—esophageal cancer	0.000935	0.00229	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Capecitabine—esophageal cancer	0.000926	0.00227	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000924	0.0017	CbGpPWpGaD
Chenodeoxycholic acid—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000921	0.00225	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Capecitabine—esophageal cancer	0.000913	0.00223	CcSEcCtD
Chenodeoxycholic acid—Dysuria—Methotrexate—esophageal cancer	0.000912	0.00223	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Cisplatin—esophageal cancer	0.000907	0.00222	CcSEcCtD
Chenodeoxycholic acid—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000906	0.00222	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Cisplatin—esophageal cancer	0.000901	0.0022	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Capecitabine—esophageal cancer	0.000899	0.0022	CcSEcCtD
Chenodeoxycholic acid—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00089	0.00218	CcSEcCtD
Chenodeoxycholic acid—Back pain—Capecitabine—esophageal cancer	0.000883	0.00216	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000883	0.00162	CbGpPWpGaD
Chenodeoxycholic acid—Decreased appetite—Cisplatin—esophageal cancer	0.000878	0.00215	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Capecitabine—esophageal cancer	0.000877	0.00215	CcSEcCtD
Chenodeoxycholic acid—Pneumonia—Methotrexate—esophageal cancer	0.000874	0.00214	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000872	0.00214	CcSEcCtD
Chenodeoxycholic acid—Infestation—Methotrexate—esophageal cancer	0.000869	0.00213	CcSEcCtD
Chenodeoxycholic acid—Infestation NOS—Methotrexate—esophageal cancer	0.000869	0.00213	CcSEcCtD
Chenodeoxycholic acid—Depression—Methotrexate—esophageal cancer	0.000867	0.00212	CcSEcCtD
Chenodeoxycholic acid—Pain—Cisplatin—esophageal cancer	0.000864	0.00211	CcSEcCtD
Chenodeoxycholic acid—Renal failure—Methotrexate—esophageal cancer	0.000855	0.00209	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Capecitabine—esophageal cancer	0.000847	0.00207	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Methotrexate—esophageal cancer	0.000845	0.00207	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP1B1—esophageal cancer	0.000844	0.00155	CbGpPWpGaD
Chenodeoxycholic acid—Anaemia—Capecitabine—esophageal cancer	0.000844	0.00206	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—TGFBR2—esophageal cancer	0.000837	0.00154	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000837	0.00154	CbGpPWpGaD
Chenodeoxycholic acid—Sweating—Methotrexate—esophageal cancer	0.000833	0.00204	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000833	0.00153	CbGpPWpGaD
Chenodeoxycholic acid—Feeling abnormal—Cisplatin—esophageal cancer	0.000833	0.00204	CcSEcCtD
Chenodeoxycholic acid—Haematuria—Methotrexate—esophageal cancer	0.000829	0.00203	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—HMOX1—esophageal cancer	0.000826	0.00152	CbGpPWpGaD
Chenodeoxycholic acid—Malaise—Capecitabine—esophageal cancer	0.000823	0.00201	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000822	0.00201	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Methotrexate—esophageal cancer	0.00082	0.00201	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Capecitabine—esophageal cancer	0.00082	0.00201	CcSEcCtD
Chenodeoxycholic acid—Syncope—Capecitabine—esophageal cancer	0.000818	0.002	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Capecitabine—esophageal cancer	0.000817	0.002	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Capecitabine—esophageal cancer	0.000807	0.00197	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Capecitabine—esophageal cancer	0.000802	0.00196	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Cisplatin—esophageal cancer	0.000799	0.00196	CcSEcCtD
Chenodeoxycholic acid—Cough—Capecitabine—esophageal cancer	0.000796	0.00195	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CA1—esophageal cancer	0.000796	0.00146	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—SLC10A2—esophageal cancer	0.000796	0.00146	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP19A1—esophageal cancer	0.000794	0.00146	CbGpPWpGaD
Chenodeoxycholic acid—Hypertension—Capecitabine—esophageal cancer	0.000788	0.00193	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Methotrexate—esophageal cancer	0.000784	0.00192	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000784	0.00144	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000783	0.00144	CbGpPWpGaD
Chenodeoxycholic acid—Haemorrhage—Methotrexate—esophageal cancer	0.00078	0.00191	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00078	0.00143	CbGpPWpGaD
Chenodeoxycholic acid—Arthralgia—Capecitabine—esophageal cancer	0.000777	0.0019	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Capecitabine—esophageal cancer	0.000777	0.0019	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Capecitabine—esophageal cancer	0.000777	0.0019	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Methotrexate—esophageal cancer	0.000775	0.0019	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000774	0.00142	CbGpPWpGaD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000772	0.00189	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Methotrexate—esophageal cancer	0.000771	0.00189	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00077	0.00141	CbGpPWpGaD
Chenodeoxycholic acid—Discomfort—Capecitabine—esophageal cancer	0.000768	0.00188	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000768	0.00141	CbGpPWpGaD
Chenodeoxycholic acid—Urethral disorder—Methotrexate—esophageal cancer	0.000765	0.00187	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Capecitabine—esophageal cancer	0.00076	0.00186	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Methotrexate—esophageal cancer	0.000752	0.00184	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Capecitabine—esophageal cancer	0.000751	0.00184	CcSEcCtD
Chenodeoxycholic acid—Oedema—Capecitabine—esophageal cancer	0.000745	0.00182	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Cisplatin—esophageal cancer	0.000744	0.00182	CcSEcCtD
Chenodeoxycholic acid—Infection—Capecitabine—esophageal cancer	0.00074	0.00181	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000735	0.00135	CbGpPWpGaD
Chenodeoxycholic acid—Shock—Capecitabine—esophageal cancer	0.000733	0.00179	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Capecitabine—esophageal cancer	0.00073	0.00179	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Methotrexate—esophageal cancer	0.000729	0.00179	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Capecitabine—esophageal cancer	0.000729	0.00178	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CA2—esophageal cancer	0.000728	0.00134	CbGpPWpGaD
Chenodeoxycholic acid—Tinnitus—Methotrexate—esophageal cancer	0.000728	0.00178	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Capecitabine—esophageal cancer	0.000727	0.00178	CcSEcCtD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—EP300—esophageal cancer	0.000726	0.00133	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Cisplatin—esophageal cancer	0.000725	0.00177	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Methotrexate—esophageal cancer	0.000724	0.00177	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Capecitabine—esophageal cancer	0.000724	0.00177	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Capecitabine—esophageal cancer	0.00072	0.00176	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—esophageal cancer	0.000719	0.00132	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000712	0.00131	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—esophageal cancer	0.000711	0.00131	CbGpPWpGaD
Chenodeoxycholic acid—Anorexia—Capecitabine—esophageal cancer	0.00071	0.00174	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Methotrexate—esophageal cancer	0.000708	0.00173	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Methotrexate—esophageal cancer	0.000705	0.00173	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Methotrexate—esophageal cancer	0.000703	0.00172	CcSEcCtD
Chenodeoxycholic acid—Chills—Methotrexate—esophageal cancer	0.0007	0.00171	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000697	0.00128	CbGpPWpGaD
Chenodeoxycholic acid—Hypotension—Capecitabine—esophageal cancer	0.000696	0.0017	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Cisplatin—esophageal cancer	0.000691	0.00169	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Methotrexate—esophageal cancer	0.00069	0.00169	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—SMG6—esophageal cancer	0.000685	0.00126	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—BLVRB—esophageal cancer	0.000684	0.00126	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—SLC52A3—esophageal cancer	0.000684	0.00126	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000684	0.00126	CbGpPWpGaD
Chenodeoxycholic acid—Malnutrition—Methotrexate—esophageal cancer	0.000679	0.00166	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000679	0.00166	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—PLCE1—esophageal cancer	0.000677	0.00124	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ADH7—esophageal cancer	0.000677	0.00124	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000677	0.00124	CbGpPWpGaD
Chenodeoxycholic acid—Insomnia—Capecitabine—esophageal cancer	0.000674	0.00165	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000669	0.00123	CbGpPWpGaD
Chenodeoxycholic acid—Paraesthesia—Capecitabine—esophageal cancer	0.000669	0.00164	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Capecitabine—esophageal cancer	0.000664	0.00163	CcSEcCtD
Chenodeoxycholic acid—Back pain—Methotrexate—esophageal cancer	0.000657	0.00161	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Capecitabine—esophageal cancer	0.000656	0.0016	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Capecitabine—esophageal cancer	0.000648	0.00158	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000643	0.00157	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Cisplatin—esophageal cancer	0.000642	0.00157	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Capecitabine—esophageal cancer	0.000642	0.00157	CcSEcCtD
Chenodeoxycholic acid—Rash—Cisplatin—esophageal cancer	0.000637	0.00156	CcSEcCtD
Chenodeoxycholic acid—Constipation—Capecitabine—esophageal cancer	0.000637	0.00156	CcSEcCtD
Chenodeoxycholic acid—Pain—Capecitabine—esophageal cancer	0.000637	0.00156	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Cisplatin—esophageal cancer	0.000637	0.00156	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000636	0.00117	CbGpPWpGaD
Chenodeoxycholic acid—Ill-defined disorder—Methotrexate—esophageal cancer	0.00063	0.00154	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Methotrexate—esophageal cancer	0.000628	0.00154	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Capecitabine—esophageal cancer	0.000614	0.0015	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000613	0.00113	CbGpPWpGaD
Chenodeoxycholic acid—Malaise—Methotrexate—esophageal cancer	0.000613	0.0015	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000612	0.00112	CbGpPWpGaD
Chenodeoxycholic acid—Vertigo—Methotrexate—esophageal cancer	0.00061	0.00149	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000609	0.00149	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Methotrexate—esophageal cancer	0.000608	0.00149	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000607	0.00111	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Cisplatin—esophageal cancer	0.0006	0.00147	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—ADH1B—esophageal cancer	0.000594	0.00109	CbGpPWpGaD
Chenodeoxycholic acid—Cough—Methotrexate—esophageal cancer	0.000593	0.00145	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Capecitabine—esophageal cancer	0.000592	0.00145	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Capecitabine—esophageal cancer	0.000589	0.00144	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Capecitabine—esophageal cancer	0.000589	0.00144	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Methotrexate—esophageal cancer	0.000589	0.00144	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000584	0.00107	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—SLC10A2—esophageal cancer	0.000582	0.00107	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CA1—esophageal cancer	0.000582	0.00107	CbGpPWpGaD
Chenodeoxycholic acid—Myalgia—Methotrexate—esophageal cancer	0.000578	0.00142	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Methotrexate—esophageal cancer	0.000578	0.00142	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Methotrexate—esophageal cancer	0.000578	0.00142	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000574	0.00141	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Methotrexate—esophageal cancer	0.000571	0.0014	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—TYMP—esophageal cancer	0.000567	0.00104	CbGpPWpGaD
Chenodeoxycholic acid—Confusional state—Methotrexate—esophageal cancer	0.000559	0.00137	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000559	0.00103	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000557	0.00102	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP26A1—esophageal cancer	0.000552	0.00101	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000551	0.00101	CbGpPWpGaD
Chenodeoxycholic acid—Infection—Methotrexate—esophageal cancer	0.000551	0.00135	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Capecitabine—esophageal cancer	0.000549	0.00134	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Methotrexate—esophageal cancer	0.000544	0.00133	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Methotrexate—esophageal cancer	0.000543	0.00133	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Methotrexate—esophageal cancer	0.000539	0.00132	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—ALOX15—esophageal cancer	0.000538	0.000988	CbGpPWpGaD
Chenodeoxycholic acid—Hyperhidrosis—Methotrexate—esophageal cancer	0.000536	0.00131	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Capecitabine—esophageal cancer	0.000534	0.00131	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CA2—esophageal cancer	0.000532	0.000978	CbGpPWpGaD
Chenodeoxycholic acid—Anorexia—Methotrexate—esophageal cancer	0.000529	0.00129	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Capecitabine—esophageal cancer	0.000527	0.00129	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000524	0.000962	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.00052	0.000956	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—NR1I2—esophageal cancer	0.000519	0.000953	CbGpPWpGaD
Chenodeoxycholic acid—Hypotension—Methotrexate—esophageal cancer	0.000518	0.00127	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTO1—esophageal cancer	0.000513	0.000943	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—TPI1—esophageal cancer	0.000513	0.000943	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Capecitabine—esophageal cancer	0.00051	0.00125	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—SMAD4—esophageal cancer	0.00051	0.000936	CbGpPWpGaD
Chenodeoxycholic acid—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000505	0.00124	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Methotrexate—esophageal cancer	0.000502	0.00123	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Methotrexate—esophageal cancer	0.000498	0.00122	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—ADH7—esophageal cancer	0.000495	0.000909	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PLCE1—esophageal cancer	0.000495	0.000909	CbGpPWpGaD
Chenodeoxycholic acid—Dyspnoea—Methotrexate—esophageal cancer	0.000494	0.00121	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Methotrexate—esophageal cancer	0.000493	0.00121	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Capecitabine—esophageal cancer	0.000493	0.00121	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—ALDOB—esophageal cancer	0.000492	0.000904	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	0.00049	0.0009	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000489	0.000899	CbGpPWpGaD
Chenodeoxycholic acid—Dyspepsia—Methotrexate—esophageal cancer	0.000488	0.00119	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—digestive system—esophageal cancer	0.000484	0.0296	CbGeAlD
Chenodeoxycholic acid—Decreased appetite—Methotrexate—esophageal cancer	0.000482	0.00118	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000482	0.000885	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000479	0.00117	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Methotrexate—esophageal cancer	0.000478	0.00117	CcSEcCtD
Chenodeoxycholic acid—Pain—Methotrexate—esophageal cancer	0.000474	0.00116	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GAPDH—esophageal cancer	0.000474	0.00087	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Capecitabine—esophageal cancer	0.000474	0.00116	CcSEcCtD
Chenodeoxycholic acid—Rash—Capecitabine—esophageal cancer	0.00047	0.00115	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CRABP1—esophageal cancer	0.000469	0.000862	CbGpPWpGaD
Chenodeoxycholic acid—Dermatitis—Capecitabine—esophageal cancer	0.000469	0.00115	CcSEcCtD
Chenodeoxycholic acid—Headache—Capecitabine—esophageal cancer	0.000467	0.00114	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Methotrexate—esophageal cancer	0.000457	0.00112	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000453	0.00111	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000453	0.000832	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00045	0.000827	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GNG7—esophageal cancer	0.000446	0.00082	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—HIST1H2BM—esophageal cancer	0.000445	0.000818	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000444	0.000816	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Capecitabine—esophageal cancer	0.000442	0.00108	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Methotrexate—esophageal cancer	0.000441	0.00108	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Methotrexate—esophageal cancer	0.000438	0.00107	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Methotrexate—esophageal cancer	0.000438	0.00107	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—ADH1B—esophageal cancer	0.000434	0.000797	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000429	0.000789	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—BLVRB—esophageal cancer	0.000427	0.000784	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—SLC52A3—esophageal cancer	0.000427	0.000784	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000424	0.00078	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000423	0.000778	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ALDH2—esophageal cancer	0.000418	0.000769	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000418	0.000768	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—TYMP—esophageal cancer	0.000415	0.000762	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000414	0.000761	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Methotrexate—esophageal cancer	0.000409	0.001	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000407	0.000748	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP26A1—esophageal cancer	0.000403	0.000741	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTT1—esophageal cancer	0.000398	0.000731	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Methotrexate—esophageal cancer	0.000398	0.000974	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP2A6—esophageal cancer	0.000393	0.000723	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ALOX15—esophageal cancer	0.000393	0.000722	CbGpPWpGaD
Chenodeoxycholic acid—Pruritus—Methotrexate—esophageal cancer	0.000392	0.00096	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000392	0.00072	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Methotrexate—esophageal cancer	0.000379	0.000929	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000376	0.00069	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTO1—esophageal cancer	0.000375	0.000689	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—TPI1—esophageal cancer	0.000375	0.000689	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ENO1—esophageal cancer	0.000373	0.000685	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTGS1—esophageal cancer	0.000373	0.000685	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PSME2—esophageal cancer	0.000367	0.000675	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PSME1—esophageal cancer	0.000367	0.000675	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Methotrexate—esophageal cancer	0.000367	0.000897	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000365	0.000671	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000363	0.000667	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—SLC10A2—esophageal cancer	0.000363	0.000666	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CA1—esophageal cancer	0.000363	0.000666	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ALDOB—esophageal cancer	0.00036	0.000661	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Methotrexate—esophageal cancer	0.000353	0.000863	CcSEcCtD
Chenodeoxycholic acid—Rash—Methotrexate—esophageal cancer	0.00035	0.000856	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Methotrexate—esophageal cancer	0.000349	0.000855	CcSEcCtD
Chenodeoxycholic acid—Headache—Methotrexate—esophageal cancer	0.000347	0.00085	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—GAPDH—esophageal cancer	0.000346	0.000636	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—PSME2—esophageal cancer	0.000345	0.000634	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—PSME1—esophageal cancer	0.000345	0.000634	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000343	0.000631	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CRABP1—esophageal cancer	0.000343	0.00063	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000341	0.000626	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000338	0.00062	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000333	0.000612	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CA2—esophageal cancer	0.000332	0.000609	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Methotrexate—esophageal cancer	0.000329	0.000806	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—GNG7—esophageal cancer	0.000326	0.000599	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—NOTCH3—esophageal cancer	0.000326	0.000598	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000321	0.000589	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP1B1—esophageal cancer	0.000317	0.000582	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000314	0.000577	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.00031	0.000569	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PLCE1—esophageal cancer	0.000308	0.000567	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ADH7—esophageal cancer	0.000308	0.000567	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ALDH2—esophageal cancer	0.000306	0.000562	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP19A1—esophageal cancer	0.000298	0.000548	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—NOTCH2—esophageal cancer	0.000292	0.000537	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTT1—esophageal cancer	0.000291	0.000534	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP2A6—esophageal cancer	0.000287	0.000528	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000286	0.000526	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTGS1—esophageal cancer	0.000272	0.000501	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ENO1—esophageal cancer	0.000272	0.000501	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000272	0.0005	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—HMOX1—esophageal cancer	0.000272	0.0005	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ADH1B—esophageal cancer	0.00027	0.000497	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PSME2—esophageal cancer	0.000269	0.000493	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PSME1—esophageal cancer	0.000269	0.000493	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000267	0.00049	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ABCB1—esophageal cancer	0.000261	0.00048	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—TYMP—esophageal cancer	0.000258	0.000475	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000256	0.00047	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP26A1—esophageal cancer	0.000251	0.000462	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—SMAD4—esophageal cancer	0.000245	0.000451	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ALOX15—esophageal cancer	0.000245	0.00045	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000243	0.000447	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000241	0.000442	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000234	0.000431	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—TPI1—esophageal cancer	0.000234	0.000429	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTO1—esophageal cancer	0.000234	0.000429	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP1B1—esophageal cancer	0.000232	0.000426	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000228	0.000419	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ALDOB—esophageal cancer	0.000224	0.000412	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP19A1—esophageal cancer	0.000218	0.0004	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GAPDH—esophageal cancer	0.000216	0.000396	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CRABP1—esophageal cancer	0.000214	0.000393	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GNG7—esophageal cancer	0.000203	0.000374	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—MYC—esophageal cancer	0.000202	0.000371	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—HMOX1—esophageal cancer	0.000199	0.000365	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000197	0.000363	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000195	0.000358	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000194	0.000356	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000191	0.000351	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ABCB1—esophageal cancer	0.000191	0.000351	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ALDH2—esophageal cancer	0.000191	0.00035	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000182	0.000335	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTT1—esophageal cancer	0.000181	0.000333	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—NOTCH1—esophageal cancer	0.000181	0.000332	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00018	0.00033	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP2A6—esophageal cancer	0.000179	0.000329	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CREBBP—esophageal cancer	0.000174	0.000321	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ENO1—esophageal cancer	0.00017	0.000312	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTGS1—esophageal cancer	0.00017	0.000312	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PSME2—esophageal cancer	0.000167	0.000307	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PSME1—esophageal cancer	0.000167	0.000307	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—CREBBP—esophageal cancer	0.000164	0.000301	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—NOS3—esophageal cancer	0.000156	0.000287	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP1B1—esophageal cancer	0.000144	0.000265	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000144	0.000265	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTGS2—esophageal cancer	0.000143	0.000262	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP19A1—esophageal cancer	0.000136	0.000249	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CREBBP—esophageal cancer	0.000128	0.000234	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—HMOX1—esophageal cancer	0.000124	0.000228	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ABCB1—esophageal cancer	0.000119	0.000218	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—EP300—esophageal cancer	0.000119	0.000218	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NOS3—esophageal cancer	0.000114	0.00021	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTGS2—esophageal cancer	0.000104	0.000192	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLC52A3—esophageal cancer	9.8e-05	0.00018	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—BLVRB—esophageal cancer	9.8e-05	0.00018	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—MYC—esophageal cancer	9.73e-05	0.000179	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CA—esophageal cancer	8.79e-05	0.000161	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—EP300—esophageal cancer	8.68e-05	0.00016	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CA1—esophageal cancer	8.33e-05	0.000153	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLC10A2—esophageal cancer	8.33e-05	0.000153	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CREBBP—esophageal cancer	7.95e-05	0.000146	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CA2—esophageal cancer	7.62e-05	0.00014	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NOS3—esophageal cancer	7.12e-05	0.000131	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PLCE1—esophageal cancer	7.08e-05	0.00013	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ADH7—esophageal cancer	7.08e-05	0.00013	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTGS2—esophageal cancer	6.51e-05	0.00012	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CA—esophageal cancer	6.42e-05	0.000118	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ADH1B—esophageal cancer	6.21e-05	0.000114	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TYMP—esophageal cancer	5.94e-05	0.000109	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP26A1—esophageal cancer	5.77e-05	0.000106	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ALOX15—esophageal cancer	5.63e-05	0.000103	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—EP300—esophageal cancer	5.41e-05	9.94e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTO1—esophageal cancer	5.37e-05	9.86e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TPI1—esophageal cancer	5.37e-05	9.86e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.15e-05	9.45e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GAPDH—esophageal cancer	4.95e-05	9.1e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CRABP1—esophageal cancer	4.91e-05	9.02e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GNG7—esophageal cancer	4.67e-05	8.58e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.38e-05	8.04e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.16e-05	7.65e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.11e-05	7.56e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CA—esophageal cancer	4e-05	7.36e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ENO1—esophageal cancer	3.9e-05	7.17e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTGS1—esophageal cancer	3.9e-05	7.17e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PSME2—esophageal cancer	3.84e-05	7.06e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PSME1—esophageal cancer	3.84e-05	7.06e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.32e-05	6.09e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.12e-05	5.73e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.85e-05	5.23e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.73e-05	5.02e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.83e-05	3.35e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NOS3—esophageal cancer	1.63e-05	3e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.49e-05	2.75e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—EP300—esophageal cancer	1.24e-05	2.28e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CA—esophageal cancer	9.2e-06	1.69e-05	CbGpPWpGaD
